Eli Lilly's new weight-loss drug shows up to 28% loss, beating rivals. FDA filing soon.
PGNY jumps 2.6% on upgrade, beats 6 qtrs of earnings. Faces volatility, down 4.2% YTD.
KRUS jumps 5.4% on Trump's $1M-$5M stake buy; same-store sales up 8.6%. Valuation metrics look strong.
Retailers beat earnings, but Walmart's tepid guidance sparks trader jitters. Consumers defy low sentiment.
WSM beats EPS estimates 7.3%, revenue in line. Same-store sales up 4.8%. Stock up 2.2%.
TJX beats EPS estimates with 29% growth; margins widen. Stock up 5.7%, but valuation is a watchpoint.
EasyJet's losses widen 27% on fuel costs & lower bookings; revenue up 12%. Shares dip.
Sponsored
Must Read